Long-term survival of a BRCA2 mutation carrier following second ovarian cancer relapse using PARPi therapy: A case report

BRCA1/2 mutation carriers have lifelong increased risks of developing breast and ovarian cancer. Due to the lack of efficient ovarian cancer screening, patients mainly present when the tumors are at an advanced stage, and the long-term survival is poor. The application of poly(ADP-ribose) polymerase...

Descripción completa

Detalles Bibliográficos
Autores principales: Bredow, Kathrin, Blümcke, Britta, Schneider, Stephanie, Püsken, Michael, Schmutzler, Rita, Rhiem, Kerstin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353872/
https://www.ncbi.nlm.nih.gov/pubmed/35949895
http://dx.doi.org/10.3892/mco.2022.2570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353872/
https://www.ncbi.nlm.nih.gov/pubmed/35949895
http://dx.doi.org/10.3892/mco.2022.2570

Ejemplares similares